ETN
79
4
JNJ
44
3
FDX
40
4
PPG
60
3
NWS
69
7
NTRS
57
2
DRI
48
3
STT
64
4
SHW
65
7
XYL
45
8
MCD
50
-2
DE
56
10
HD
55
8
ROP
59
5
ABBV
39
8
STI
31
-16
MU
36
5
OMC
61
6
BK
72
4
URI
60
7
ETN
79
4
JNJ
44
3
FDX
40
4
PPG
60
3
NWS
69
7
NTRS
57
2
DRI
48
3
STT
64
4
SHW
65
7
XYL
45
8
MCD
50
-2
DE
56
10
HD
55
8
ROP
59
5
ABBV
39
8
STI
31
-16
MU
36
5
OMC
61
6
BK
72
4
URI
60
7
Financhill
Back

Entrada Therapeutics Vs. Regenxbio Industry Stock Comparison

Buy
58

TRDA
Entrada Therapeutics

Last Price:
18.85
Seasonality Move:
-29.61%
Sell
18

RGNX
Regenxbio

Last Price:
9.60
Seasonality Move:
-5.7%
Buy
58
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $18.05. The Score for TRDA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $9.18. The Score for RGNX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $18.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $9.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing slight buying pressure.

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.32 Buy
Relative Strength Index (14 RSI): 50.91 Buy
Chaikin Money Flow: 10625 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 43.02 Sell
Chaikin Money Flow: -473643 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.48 Sell
20-day SMA: 18.27 Sell
50-day SMA: 16.93 Buy
200-day SMA: 15.19 Buy
8-day EMA: 18.24 Sell
20-day EMA: 18.15 Sell
50-day EMA: 17.37 Buy
200-day EMA: 15.84 Buy

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.06 Sell
20-day SMA: 9.77 Sell
50-day SMA: 10.34 Sell
200-day SMA: 14.27 Sell
8-day EMA: 9.84 Sell
20-day EMA: 9.96 Sell
50-day EMA: 10.39 Sell
200-day EMA: 13.22 Sell

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):